Skip to main content
logo
Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.24
+0.06 (0.97%)
At close: Jun 8, 2026, 4:00 PM EDT
6.32
+0.08 (1.28%)
After-hours: Jun 8, 2026, 5:49 PM EDT

Xeris Biopharma Holdings Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
1,0771,305507325181366
Market Cap Growth
37.84%157.58%56.05%79.10%-50.46%24.75%
Enterprise Value
1,2241,446685.21477.85255.75351.51
Last Close Price
6.247.853.392.351.332.93
PE Ratio
97.342447.71----
Forward PE
49.2564.50----
PS Ratio
3.424.472.491.981.647.38
PB Ratio
82.7695.32-17.10-47.864.013.84
P/TBV Ratio
83.3099.06-16.80-47.703.992.43
P/FCF Ratio
22.6746.72----
P/OCF Ratio
22.2045.58----
EV/Sales Ratio
3.894.953.372.922.327.09
EV/EBITDA Ratio
25.4639.02----
EV/EBIT Ratio
34.1058.07----
EV/FCF Ratio
25.7651.76----
Debt / Equity Ratio
19.3918.40-8.45-33.284.350.92
Debt / EBITDA Ratio
5.386.97----
Debt / FCF Ratio
5.449.24----
Net Debt / Equity Ratio
11.2810.74-6.75-23.111.68-0.15
Net Debt / EBITDA Ratio
3.053.97-9.26-4.95-1.090.13
Net Debt / FCF Ratio
3.095.27-5.28-3.18-0.740.15
Asset Turnover
0.810.830.630.490.340.21
Inventory Turnover
0.620.730.850.901.061.01
Quick Ratio
1.421.481.121.172.081.52
Current Ratio
2.122.191.671.642.541.80
Return on Equity (ROE)
89.95%-6.96%301.32%-324.20%-134.83%-190.28%
Return on Assets (ROA)
9.26%7.05%-10.01%-12.93%-24.88%-49.69%
Return on Invested Capital (ROIC)
20.73%14.16%-16.51%-22.98%-49.57%-134.67%
Return on Capital Employed (ROCE)
13.12%10.03%-14.95%-17.66%-33.03%-64.65%
Earnings Yield
1.11%0.04%----
FCF Yield
4.41%2.14%----
Buyback Yield / Dilution
-19.55%-17.69%-6.61%-1.51%-71.62%-85.32%
Total Shareholder Return
-19.55%-17.69%-6.61%-1.51%-71.62%-85.32%
SEC Filings: 10-K · 10-Q